Evidence map›Paper›PMID 40836942›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

The Mobile Toolbox for remote, self-administered cognitive assessment in older adults: associations with in-clinic cognitive testing and Alzheimer's disease biomarkers.

Roos J Jutten, Jessa E Burling, Elliott Slade, Jackson C Thompson, Jessie Fanglu Fu, Colin Birkenbihl, Michael J Properzi, Gad A Marshall, Rebecca E Amariglio, Kathryn V Papp and 4 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Roos J JuttenDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.ORCID https://orcid.org/0000-0002-3712-4790
Jessa E BurlingDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Elliott SladeDepartment of Radiology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Jackson C ThompsonDepartment of Radiology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Jessie Fanglu FuDepartment of Radiology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Colin BirkenbihlDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Michael J ProperziDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Gad A MarshallDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Rebecca E AmariglioDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Kathryn V PappDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Keith A JohnsonDepartment of Radiology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Julie C PriceDepartment of Radiology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Reisa A SperlingDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.
Dorene M RentzDepartment of Neurology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA.

Funding

Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Rachel Frances Buckley · 2010 to 2026
$50.2M
The MobileToolbox for Monitoring Cognitive Function - Technical CoreU2CAG060426 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Aaron James Kaat · 2018 to 2026
$35.0M
Novel automated performance-based ADL outcomes for early AD clinical trialsR01AG053184 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI MARSHALL, GAD ASHER · 2018 to 2023
$4.5M
Characterizing the evolution of Subjective Cognitive Decline in preclinical Alzheimer's diseaseR01AG058825 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI AMARIGLIO, REBECCA E · 2019 to 2024
$4.0M
Neural Correlates of Apathy Across the Alzheimer's Disease ContinuumR01AG067021 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI MARSHALL, GAD ASHER · 2020 to 2025
$3.6M
Development and validation of efficient cognitive composite scores of digital tools for the detection of early pathophysiological changes in Alzheimers diseaseK99AG081457 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI FU, FANG LU (JESSIE) · 2023 to 2024
$254k
NIA NIH HHS K99 AG081457NIA NIH HHS P01 AG036694NIA NIH HHS R01 AG053184NIA NIH HHS R01 AG058825NIA NIH HHS R01 AG067021NIA NIH HHS U2C AG060426
6 · The paper itself

Abstract

introductionRemote, smartphone-based cognitive assessments such as the Mobile Toolbox (MTB) may increase the accessibility of Alzheimer's disease (AD) clinical trials. We examined the feasibility of the MTB among cognitively unimpaired (CU) older adults and investigated its associations with standardized in-clinic cognitive testing and amyloid and tau positron emission tomography imaging.

methodsA total of 100 CU older adults self-administered the MTB remotely on their personal devices. Linear regression models correcting for demographics investigated associations of MTB fluid and crystallized cognition composites with in-clinic Preclinical Alzheimer's Cognitive Composite-5 (PACC-5) scores, global amyloid-beta burden and tau deposition in the medial-temporal lobe and neocortex.

resultsMost participants completed the MTB without requiring assistance (81%) or reminders (61%). MTB fluid cognition scores were positively associated with PACC-5 scores and negatively with tau deposition in the medial-temporal lobe and neocortex. DISCUSSION: These findings suggest that the MTB may provide a feasible approach to capture cognitive processes relevant in preclinical AD. Highlights: The Mobile Toolbox (MTB) is a remote smartphone-based cognitive assessment.We deployed the MTB in CU older adults with Alzheimer's disease (AD) biomarkers.We show how the MTB may facilitate cognitive assessment in preclinical AD research.

Indexed as

Alzheimer's diseaseamyloidcognitionremote assessmenttau

Identifiers

PMID40836942
PMCPMC12362792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.